Concepedia

Mahila Ferrari

MF

Statistics

Publications

52

Citations

3.6K

H-Index

31

Active since

1999

Affiliations

European Institute of Oncology(Current)

Ripamonti

Istituti di Ricovero e Cura a Carattere Scientifico

University of Milan

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Mahila Ferrari is an author at European Institute of Oncology specializing in medicine, nuclear medicine, and radiation oncology.

ORCID

Top concepts

Publications per year

1999–2025

52

Publications

52

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

Lisa Bodei, Marta Cremonesi, Mahila Ferrari et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 413 citations

, , +10

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Lisa Bodei, Marta Cremonesi, Chiara Maria Grana et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 411 citations

, , +11

Safety of sentinel node biopsy in pregnant patients with breast cancer

Oreste ­Gentilini, Marta Cremonesi, Giuseppe Trifirò et al. · Annals of Oncology · 2004 · 229 citations · Full text

, , +7

Dosimetry in Peptide radionuclide receptor therapy: a review.

Marta Cremonesi, Mahila Ferrari, Lisa Bodei et al. · PubMed · 2006 · 206 citations

, , +11

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

Giovanni Paganelli, Stefania Zoboli, Marta Cremonesi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 205 citations

, , +2

1–5 of 52